• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.27% Nasdaq Up 0.11%

    Momenta Pharmaceuticals Inc. (MNTA)

    -NasdaqGS
    9.19 Down 0.29(3.09%) 10:50AM EDT - Nasdaq Real Time Price
    Prev Close:9.48
    Open:9.53
    Bid:9.20 x 400
    Ask:9.22 x 200
    1y Target Est:16.56
    Beta:1.72844
    Earnings Date:Aug 2 - Aug 8 (Est.)
    Day's Range:9.14 - 9.53
    52wk Range:7.86 - 25.56
    Volume:165,586
    Avg Vol (3m):634,697
    Market Cap:643.45M
    P/E (ttm):N/A
    EPS (ttm):-1.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MNTA

    Comparison

    Symbol% ChgMkt Cap
    MNTADown 3.09%643.45M
    GSKDown 0.02%102.46B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):7.21
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.23
    Quarterly EPS Est (Jun-16) :-0.33
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback